Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Dessolin

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Expert Opinion on Therapeutic Patents|November 14, 2013
N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl)-amides as BACE1 inhibitors: a patent evaluation of WO2013041499Jean Dessolin
Redox Report : Communications in Free Radical Research|February 14, 2004
Double-drug development against antioxidant enzymes from Plasmodium falciparumChristophe Biot, Jean Dessolin, Philippe Grellier, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 23, 2010
Description and assessment of a model for GSK-3beta database virtual screeningNadege Ventimila, Pierre-Yves Dupont, Michel Laguerre, et al.
European Journal of Pharmacology|August 2, 2002
Selective targeting of synthetic antioxidants to mitochondria: towards a mitochondrial medicine for neurodegenerative diseases?Jean Dessolin, Marie Schuler, Alice Quinart, et al.
Bioorganic & Medicinal Chemistry|January 30, 2024
Synergistic effect of tryptamine-urea derivatives to overcome the chromosomally-mediated colistin resistance in Klebsiella pneumoniaeChaimae Majdi, Jean Dessolin, David Bénimélis, et al.
Bioconjugate Chemistry|April 29, 2026
Lipid and Carbohydrate Modifications Enhance Potency of Antisense Oligonucleotides Targeting Oncogenic KRASFaith Kivunga, Virginie Baylot, Julien Verget, et al.
Scientific Reports|October 12, 2019
A Complex Interplay of Anionic Phospholipid Binding Regulates 3'-Phosphoinositide-Dependent-Kinase-1 Homodimer ActivationGloria de Las Heras-Martínez, Véronique Calleja, Remy Bailly, et al.
Bioconjugate Chemistry|October 28, 2017
Last-Step Pd-Mediated [<sup>11</sup>C]CO Labeling of a Moxestrol-Conjugated o-Iodobenzyl Alcohol: From Model Experiments to in Vivo Positron Emission Tomography StudiesThomas Cornilleau, Mette Simonsen, Maylou Vang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 16, 2011
Novel phenyl(thio)ureas bearing (thio)oxothiazoline group as potential BACE-1 inhibitors: synthesis and biological evaluationFederico Andreoli, Abdallah Larbi Doukara, Mohammed Amine Mehdid, et al.
The Biochemical Journal|November 28, 2012
A novel small-molecule screening strategy identifies mitoxantrone as a RhoGTPase inhibitorAurélien Bidaud-Meynard, Daniela Arma, Said Taouji, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Patents|November 14, 2013
N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl)-amides as BACE1 inhibitors: a patent evaluation of WO2013041499Jean Dessolin
Redox Report : Communications in Free Radical Research|February 14, 2004
Double-drug development against antioxidant enzymes from Plasmodium falciparumChristophe Biot, Jean Dessolin, Philippe Grellier, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 23, 2010
Description and assessment of a model for GSK-3beta database virtual screeningNadege Ventimila, Pierre-Yves Dupont, Michel Laguerre, et al.
European Journal of Pharmacology|August 2, 2002
Selective targeting of synthetic antioxidants to mitochondria: towards a mitochondrial medicine for neurodegenerative diseases?Jean Dessolin, Marie Schuler, Alice Quinart, et al.
Bioorganic & Medicinal Chemistry|January 30, 2024
Synergistic effect of tryptamine-urea derivatives to overcome the chromosomally-mediated colistin resistance in Klebsiella pneumoniaeChaimae Majdi, Jean Dessolin, David Bénimélis, et al.
Bioconjugate Chemistry|April 29, 2026
Lipid and Carbohydrate Modifications Enhance Potency of Antisense Oligonucleotides Targeting Oncogenic KRASFaith Kivunga, Virginie Baylot, Julien Verget, et al.
Scientific Reports|October 12, 2019
A Complex Interplay of Anionic Phospholipid Binding Regulates 3'-Phosphoinositide-Dependent-Kinase-1 Homodimer ActivationGloria de Las Heras-Martínez, Véronique Calleja, Remy Bailly, et al.
Bioconjugate Chemistry|October 28, 2017
Last-Step Pd-Mediated [<sup>11</sup>C]CO Labeling of a Moxestrol-Conjugated o-Iodobenzyl Alcohol: From Model Experiments to in Vivo Positron Emission Tomography StudiesThomas Cornilleau, Mette Simonsen, Maylou Vang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 16, 2011
Novel phenyl(thio)ureas bearing (thio)oxothiazoline group as potential BACE-1 inhibitors: synthesis and biological evaluationFederico Andreoli, Abdallah Larbi Doukara, Mohammed Amine Mehdid, et al.
The Biochemical Journal|November 28, 2012
A novel small-molecule screening strategy identifies mitoxantrone as a RhoGTPase inhibitorAurélien Bidaud-Meynard, Daniela Arma, Said Taouji, et al.
Pageof 2